Other assessments: Prostate size and prostate specific antigen

BJU International, Supplement

Volumn 85, Issue 1, 2000, Pages 31-35

  Williams, G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

BLADDER PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; MICROWAVE IRRADIATION; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TRANSURETHRAL RESECTION; URINARY TRACT OBSTRUCTION;

EID: 0034064595     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.2000.00031.x     Document Type: Review

References (51)

1. Mebust W, Holtgrewe L, Cockett A, Peters PC. Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243-7
2. Girman CJ, Jacobsen SJ, Guess HA et al. Natural history of prostatism. Relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 1995; 153: 1510-15
3. Jacobsen SJ, Girman CJ, Guess HA, Rhodes T, Oesterling JE, Lieber MM. Natural history of prostatism. Longitudinal changes in voiding symptoms in community dwelling men. J Urol 1996; 155: 595-9
4. Barry MJ, Girman CJ, O'Leary MP et al. Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease: Benign Prostatic Hyperplasia Treatment Outcomes Study Group. J Urol 1995; 153: 99-103
5. Tchetgen M-B, Oesterling JE. The role of prostate-specific antigen in the evaluation of benign prostatic hyperplasia. Urol Clin North Am 1995; 22: 333-44
6. Babaian RJ, Fritsche HA, Evans RB. Prostate-specific antigen and prostate gland volume. Correlation and clinical application. J Clin Lab Anal 1990; 4: 135-8
7. Clements R, Etherington RJ, Griffiths GJ, Peeling WB, Hughes H, Penney MD. Interrelation between measurement of serum prostate specific antigen and transrectal ultrasound in the diagnosis of benign prostatic hyperplasia and prostatic cancer. Br J Urol 1992; 70: 183-7
8. Simonsen O, Moller-Madsen B, Dorflinger T, Norgaard JP, Jorgensen SH, Lundus E. The significance of age on symptoms and urodynamic and cystoscopic findings in benign prostatic hypertrophy. Urol Res 1987; 15: 355-8
9. Styles RA, Neal DE, Powell PH. Reproducibility of measurement of prostatic volume by ultrasound. Comparison of transrectal and transabdominal methods. Eur Urol 1988; 14: 266-9
10. Kaplan SA, Te AE, Pressler LB, Olson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: Correlation with symptoms, urine flow and detrusor pressure. J Urol 1995; 154: 1764-9
11. Brawer MK. Techniques of examination. In Resnick MI, ed. Prostatic Ultrasonography. Philadelphia: BC Decker, 1990: 25
12. Rifkin MD, Resnick MI. Ultrasonography of the prostate. In Resnick MI, Rifkin MD, eds, Ultrasonography of the Urinary Tract. 3rd edn. Baltimore, Williams & Wilkins, 1991: 297
13. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991; 145: 984-7
14. Myschetzky PS, Suburu RE, Kelly BS et al. Determination of prostate gland volume by transrectal ultrasound: Correlation with radical prostatectomy specimens. Scand J Urol Nephrol 1991; 137: 107-9
15. Hricak H, Jeffrey RB, Dooms GC et al. Evaluation of prostate size: a comparison of ultrasound and magnetic resonance imaging. Urol Radiol 1987; 9: 1-5
16. El Din KE, De Wildt MJAM, Osier PFWM, Wijkstra H, Debruyne FMJ. De La Rosette JJMCH. The correlation between urodynamic and cystoscopic findings in elderly men with voiding complaints. J Urol 1996; 155: 1018-22
17. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1983; 150: 351-8
18. Holtgrewe HL. Transurethral prostatectomy. Urol Clin North Am 1995; 22: 357-68
19. McConnell J, Barry M, Bruskewitz R et al. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guidelines, no. 8. AHCPR Publication no. 94-0582. Rockville MD: Agency for Health Care Policy and Research, Public Health Service US Department of Health and Human Services 1994
20. Bruskewitz, RC, Larsen EH, Madsen P, Dortlinger T. Three year follow up of urinary symptoms after transurethral resection of the prostate. J Urol 1986; 136: 613-5
21. Orandi A. Transurethral incision of the prostate compared with transurethral resection of the prostate in 132 matching cases. J Urol 1987; 138: 810-5
22. Orandi A. Transurethral incision of the prostate (TUIP): 646 Cases in 15 years - A chronological appraisal. Br J Urol 1985; 57: 703-7
23. Soonawalla P, Pardonani D. Transurethral incision versus transurethral resection of the prostate: a subjective and objective analysis. Br J Urol 1992; 70: 174-7
24. Sirls LT, Ganabathi K, Zimmern PE, Roskamp DA, Wolde-Tsadik G, Leach GA. Transurethral incision of the prostate: An objective and subjective evaluation of long-term efficacy. J Urol 1993; 150: 1615-21
25. Edwards LE, Bucknall TE, Pittam M, Richardson DR, Stane KJ. Transurethral resection of the prostate and bladder neck incision: a review of 700 cases. Br J Urol 1985; 57: 168-71
26. Irani J, Bon D, Fournier F, Doré B, Aubert J. Patient acceptability of transurethral incision of the prostate under local anaesthesia. Br J Urol 1996; 74: 904-6
27. D'Ancona F, Netto NR, Jr, Cara AM, Ikari O. Internal urethrotomy of the prostatic urethra or transurethral resection in benign prostatic hyperplasia. J Urol 1990; 144: 918-20
28. Hellstrom P, Lukkarinen O, Kontturi M. Bladder neck incision or transurethral electroresection for the treatment of urinary obstruction caused by small benign prostate? Scan J Urol Nephrol 1986; 20: 187-92
29. Li MK, Ng ASM. Bladder neck resection and transurethral resection of the prostate: a randomised prospective trial. J Urol 1987; 138: 807-9
30. Nielson HO. Transurethral prostatotomy versus transurethral prostatectomy in benign prostatic hypertrophy. A prospective randomised study. Br J Urol 1982; 61: 435-8
31. Rechmann M, Knes JM, Heisy D, Madsen PO, Bruskewitz RC. Transurethral resection versus incision of the prostate: a randomised, prospective study. Urology 1995; 45: 768-75
32. Jahnson S, Dalen M, Gustavsson G, Pedersen J. Transurethral incision versus resection of the prostate for small to medium benign prostatic hyperplasia. Br J Urol 1998; 81: 276-81
33. Moore E, Bracken B, Bremmer W et al. Proscar: Five year experience. Eur Urol 1995; 28: 304-9
34. Marks LS, Partin AW, Gormley CJ et al. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia. J Urol 1997; 157: 2171-8
35. Montironi R, Valli M, Fabris G. Treatment of benign prostatic hyperplasia with 5 alpha reductase inhibitor: Morphological changes in patients who fail to respond. J Clin Pathol 1996; 49: 324-8
36. Rittmaster RS, Norman RW, Thomas LN et al. Evidence of atrophy and apoptosis in the prostate of men given finasteride. J Clin Endocrinol Metab 1996; 81: 814-9
37. Tewari A, Sinohara K, Narayan P. Transition zone volume transition zone ratio: Predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients. Urology 1995; 45: 258-64
38. Boyle P, Gould AL, Roehrborn CG. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomised clinical trials. Urology 1996; 48: 398-405
39. Denis L, McConnell J, Yoshida O et al. Recommendations of the International Consensus Committee. The evaluation and treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction. In Denis L, Griffiths K, Khoury S, eds. Proceedings of the 4th International Consultation on BPH, July 2-5, 1997, Paris, France. Channel Islands: Scientific Communications International, 1998: 669-83
40. Ornstein DK, Garresh SR, Smith DS, Andriole L. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. J Urol 1997; 157: 880-4
41. Veneziano S, Pavlica P, Querze R et al. Correlation between prostate-specific antigen and prostate volume evaluated by transrectal ultrasonography: Usefulness in diagnosis of prostate cancer. Eur Urol 1990; 18: 112-6
42. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cobner WH. The use of prostate-specific antigen density to enhance the predictive value of intermediate levels of serum prostate-specific antigen. J Urol 1992; 147: 817-21
43. Kalish J, Cooner WH, Graham SD. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 1994; 43: 5-8
44. Guess HA, Heyse JF, Gormley GJ, Stone RE, Oesterling JE. The effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Urol Clin North Am 1993; 20: 627-36
45. Oesterling JE, Jacobsen SJ, Chute CG et al. Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 1993; 270: 860-4
46. Partin AW, Stutzman RE. Elevated prostate-specific antigen, abnormal prostate evaluation on digital rectal examination, and transrectal ultrasound and prostate biopsy. Urol Clin North Am 1998; 25: 581-9
47. Carter HB, Pearson JD, Waclawiw Z et al. Prostate-specific antigen variability in men without prostate cancer: Effect of sampling interval on prostate-specific antigen velocity. Urology 1995; 45: 5916
48. Smith DS, Catalona WJ. Rate of change in serum prostate specific antigen levels as a method of prostate cancer detection. J Urol 1994; 152: 1163-7
49. Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men. J Urol 1994; 151: 1283-90
50. Littrip PJ, Kane RA, Mettlin CJ et al. Cost-effective prostate cancer detection. Cancer 1994; 74: 3146-58
51. Murphy CP, Barren RJ, Erickson SJ et al. Evaluation and comparison of two new prostate carcinoma markers. Cancer 1996; 78: 809-18